Arem Competitors

Delisted . USA . 
Stock . Arem Pacific
ARPCDelisted Stock  USD 0.0009  0.00  0.00%   
Arem Pacific competes with Ligand Pharmaceuticals, Epigenomics, Procyon, and Cyduct Diagnostics; as well as few others. The company conducts business under Diversified Consumer Services sector and is part of Consumer Discretionary industry. Analyzing Arem Pacific competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Arem Pacific to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Arem Pacific vs Endexx Corp Correlation

Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00090.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00080.00
Details
Naive
Forecast
LowNextHigh
0.00090.00090.0009
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00090.00090.0009
Details

Arem Pacific Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Arem Pacific and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Arem and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Arem Pacific does not affect the price movement of the other competitor.

High positive correlations

PHMB
+ 1.0
AMBD
EDXC
+ 0.63
MAHN
CHME
+ 0.57
MAHN
LGND
+ 0.56
MAHN
CHME
+ 0.41
LGND
EDXC
+ 0.26
LGND
  

High negative correlations

EPGNF
- 1.0
PHMB
EPGNF
- 1.0
AMBD
EDXC
- 0.53
PCYN
EDXC
- 0.41
CYDX
PCYN
- 0.4
LGND
CYDX
- 0.34
MAHN

Risk-Adjusted Indicators

There is a big difference between Arem Pink Sheet performing well and Arem Pacific Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arem Pacific's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AMBD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
PHMB  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MAHN  3.54 (1.75) 0.00  0.72  0.00 
 0.00 
 0.00 
 0.00 
 82.02 
CHYPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LGND  1.53 (0.17) 0.00 (0.30) 0.00 
 0.00 
 3.29 
(3.06)
 12.56 
EPGNF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
PCYN  1.60  0.83  0.00 (1.84) 0.00 
 0.00 
 0.00 
 0.00 
 46.15 
CYDX  16.23  6.93  0.00  14.41  0.00 
 0.00 
 37.50 
(22.50)
 440.74 
CHME  2.15  0.19  0.00 (0.14) 0.00 
 0.00 
 0.00 
 0.00 
 52.08 
EDXC  9.36 (1.04) 0.00 (0.20) 0.00 
 0.00 
 15.38 
(20.00)
 46.67 

Arem Pacific Competitive Analysis

The better you understand Arem Pacific competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Arem Pacific's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Arem Pacific's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ARPC AMBD PHMB MAHN LGND EPGNF PCYN CYDX CHME EDXC
 0.00 
 0.0009 
Arem
 0.00 
 0.0001 
American
 0.00 
 0.0001 
Pharmacom
 9.09 
 0.10 
Mid-Atlantic
 1.30 
 189.94 
Ligand
 0.00 
 1.12 
Epigenomics
 0.00 
 0.19 
Procyon
 1.03 
 0.98 
Cyduct
 0.00 
 0.04 
China
 33.33 
 0.0008 
Endexx
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Out of control
Very steady
Very steady
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Good
Good
Weak
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Moderate
Risky
Small
Small
Small
Small
Fair
High
Small
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Strong Buy
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Hold
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.57
0.67
N/A
1.17
1.45
3.88
4.02
1.78
11.15
0.05
Net Asset
389.03 K
1.17 M
112.36 K
8.89 M
941.77 M
24.66 M
3.8 M
N/A
66.84 M
5.22 M
Profit Margin
0.23
-0.0697
N/A
0.001
0.19
N/A
-0.0539
0.4
0.0917
N/A
EBITDA
118.37 K
147.1 K
N/A
939.29 K
40.79 M
(1.94 M)
(19.2 K)
(502.35 K)
13.41 M
(2.87 M)
Operating Margin
0.1
-0.48
N/A
0.0321
0.47
-15.9
-0.0652
-1.49
0.18
-2.63
Current Valuation
4.34 M
1.5 M
1.08 M
3.91 M
3.39 B
(9.71 M)
1.82 M
404.62 K
2 M
33.07 M
Price To Book
107.81
N/A
N/A
N/A
3.81
0.39
0.77
N/A
0.0733
N/A
Retained Earnings
(190 K)
132.09 K
(19.05 M)
1.88 M
498.98 M
(62 M)
(2.46 M)
N/A
24.76 M
(11.24 M)
Current Asset
96 K
N/A
N/A
6.4 M
214.71 M
10 M
1.88 M
N/A
94.2 M
122 K
Beta
-0.0795
18.69
168.8
1.64
1.04
1.08
-0.35
-0.42
36.82
1.17
Number Of Employees
1
N/A
N/A
1.25 K
68
36
19
3
281
6
Shares Outstanding
373.95 M
856.25 M
N/A
12.06 M
19.68 M
4.09 M
8.09 M
N/A
23.71 M
505.16 M
Cash Flow From Operations
52.74 K
110.96 K
N/A
1.28 M
97.05 M
(4.15 M)
(229.46 K)
(53.6 K)
16.96 M
(1.46 M)
Total Debt
133.14 K
61.73 K
61.54 K
401.76 K
7.11 M
966 K
694.3 K
171.98 K
4.05 M
3.37 M
Return On Equity
N/A
N/A
N/A
0.0123
0.0542
-0.38
-0.0934
0.0839
0.0663
-12.09
Z Score
1.8
N/A
N/A
3.0
N/A
0.8
2.2
1.2
1.2
1.4
Return On Asset
-0.0095
0.0024
N/A
0.0608
0.0148
-0.24
-0.0501
-0.14
0.0782
-0.6
Book Value Per Share
N/A
N/A
N/A
0.18
48.34
3.41
0.31
6.35
1.97
-0.016
Number Of Shares Shorted
N/A
N/A
N/A
N/A
1.28 M
N/A
N/A
N/A
N/A
N/A
Current Liabilities
168 K
N/A
29 K
5.46 M
222.82 M
5 M
842.7 K
N/A
8.45 M
2.46 M
Total Asset
389.03 K
1.17 M
112.36 K
8.89 M
941.77 M
24.66 M
3.8 M
N/A
66.84 M
5.22 M
Debt To Equity
N/A
N/A
N/A
2.06
0.18
0.069
0.26
0.088
0.032
N/A
Short Ratio
N/A
N/A
N/A
N/A
5.5
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
243.44
8.59
N/A
N/A
N/A
0.05
Shares Owned By Institutions
N/A
N/A
N/A
N/A
97.74
4.86
N/A
N/A
N/A
N/A
Market Capitalization
411.35 K
85.6 K
1.08 M
2.41 K
3.62 B
6.01 M
2 M
349.68 K
284.54 K
26.77 M
Price To Earning
N/A
N/A
N/A
7.0
29.74
-8.47
8.0
0.52
-6.67
-10.0
Price To Earnings To Growth
N/A
N/A
N/A
N/A
1.53
N/A
N/A
N/A
N/A
N/A
Price To Sales
13.41
0.0397
N/A
0.0063
14.4
10.64
0.4
1.12
0.01
19.81
Net Income
42.11 K
(150.5 K)
(556.18 K)
(35.2 K)
(4.03 M)
(2.43 M)
(209.79 K)
(503.79 K)
1.72 M
(4.13 M)
Earnings Per Share
N/A
N/A
N/A
0.002
2.26
-0.3
0.03
0.77
-0.009
-0.018
Shares Owned By Insiders
26.87
N/A
N/A
N/A
2.26
35.0
65.0
N/A
N/A
5.59
Revenue
262.54 K
2.16 M
N/A
28.34 M
167.13 M
6.2 M
4.84 M
344.78 K
64.75 M
1.28 M
Working Capital
(72 K)
N/A
(29 K)
937 K
294.45 M
5 M
1.04 M
N/A
85.75 M
(2.34 M)
Cash And Equivalents
59.67 K
30.43 K
N/A
750.28 K
147.94 M
15.77 M
1.04 M
13.33 K
7.85 M
6.56 K
Cash Per Share
N/A
N/A
N/A
0.06
8.76
0.96
0.13
0.04
0.2
N/A
Gross Profit
168.34 K
935.59 K
N/A
6.31 M
154.74 M
6.07 M
3.49 M
193.76 K
18.98 M
503.01 K
Day Typical Price
9.0E-4
1.0E-4
1.0E-4
0.1
189.53
1.12
0.19
0.98
0.035
8.0E-4
Accumulation Distribution
N/A
N/A
N/A
N/A
5769.08
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.0
0.0
0
0.3869
0.0
0.0
9.2 T
0.0
9.2 T
Period Momentum Indicator
N/A
N/A
N/A
(0.01)
2.43
N/A
N/A
0.01
N/A
2.0E-4
Rate Of Daily Change
1.0
1.0
1.0
0.91
1.01
1.0
1.0
1.01
1.0
1.33
Day Median Price
9.0E-4
1.0E-4
1.0E-4
0.1
189.32
1.12
0.19
0.98
0.035
8.0E-4
Price Action Indicator
N/A
N/A
N/A
(0.01)
1.83
N/A
N/A
0.005
N/A
1.0E-4
Relative Strength Index
N/A
N/A
N/A
N/A
40.13
N/A
100.0
51.11
63.85
42.26
Coefficient Of Variation
N/A
N/A
N/A
(581.70)
(1,487)
N/A
697.4
734.49
5228.54
(1,399)
Mean Deviation
N/A
N/A
N/A
3.54
1.53
N/A
1.6
16.23
2.15
9.36
Jensen Alpha
N/A
N/A
N/A
(1.75)
(0.17)
N/A
0.8347
6.93
0.1882
(1.04)
Total Risk Alpha
N/A
N/A
N/A
(2.45)
(0.26)
N/A
0.5039
4.18
(0.29)
(1.50)
Standard Deviation
N/A
N/A
N/A
10.78
2.09
N/A
5.76
51.11
8.09
11.86
Kurtosis
N/A
N/A
N/A
49.31
3.25
N/A
61.73
55.94
18.51
(0.24)
Potential Upside
N/A
N/A
N/A
N/A
3.29
N/A
N/A
37.5
N/A
15.38
Treynor Ratio
N/A
N/A
N/A
0.7155
(0.30)
N/A
(1.84)
14.41
(0.14)
(0.20)
Maximum Drawdown
N/A
N/A
N/A
82.02
12.56
N/A
46.15
440.74
52.08
46.67
Variance
N/A
N/A
N/A
116.31
4.35
N/A
33.15
2611.95
65.43
140.66
Market Risk Adjusted Performance
N/A
N/A
N/A
0.7255
(0.29)
N/A
(1.83)
14.42
(0.13)
(0.19)
Risk Adjusted Performance
N/A
N/A
N/A
(0.13)
(0.05)
N/A
0.1226
0.1181
0.0242
(0.05)
Skewness
N/A
N/A
N/A
(6.84)
(0.75)
N/A
7.77
7.22
(0.59)
(0.14)
Information Ratio
N/A
N/A
N/A
(0.18)
(0.09)
N/A
0.1342
0.1351
0.0126
(0.08)
Value At Risk
N/A
N/A
N/A
N/A
(3.06)
N/A
N/A
(22.50)
N/A
(20.00)

Arem Pacific Competition Performance Charts

Five steps to successful analysis of Arem Pacific Competition

Arem Pacific's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Arem Pacific in relation to its competition. Arem Pacific's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Arem Pacific in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Arem Pacific's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Arem Pacific, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Arem Pacific position

In addition to having Arem Pacific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run USD Crypto Assets Thematic Idea Now

USD Crypto Assets
USD Crypto Assets Theme
An experimental p2p digital currency that is accepted by many vendors in US Dollar. The USD Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Assets Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in Arem Pink Sheet

If you are still planning to invest in Arem Pacific check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arem Pacific's history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY